Evidence map›Paper›PMID 38951026›Full record

ArticleGenome research2024

CodonBERT large language model for mRNA vaccines.

Sizhen Li, Saeed Moayedpour, Ruijiang Li, Michael Bailey, Saleh Riahi, Lorenzo Kogler-Anele, Milad Miladi, Jacob Miner, Fabien Pertuy, Dinghai Zheng and 17 more

Abstract read
In one paragraph

Article in Genome research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. Review
  2. Towards mRNA therapeutics 2.0.Nature reviews. Drug discovery · 2026
    Review
  3. Cold-adapted RNA polymerase fromProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Protein Language Models in Virology: A Review of Advances and Applications.Methods in molecular biology (Clifton, N.J.) · 2026
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Sizhen Li *Digital R&D, Sanofi, Cambridge, Massachusetts 02141, USA.
Saeed Moayedpour *Digital R&D, Sanofi, Cambridge, Massachusetts 02141, USA.
Ruijiang LiDigital R&D, Sanofi, Cambridge, Massachusetts 02141, USA.
Michael BaileyDigital R&D, Sanofi, Cambridge, Massachusetts 02141, USA.
Saleh RiahiDigital R&D, Sanofi, Cambridge, Massachusetts 02141, USA.
Lorenzo Kogler-AneleDigital R&D, Sanofi, Cambridge, Massachusetts 02141, USA.
Milad MiladimRNA Center of Excellence, Sanofi, Waltham, Massachusetts 02451, USA.
Jacob MinermRNA Center of Excellence, Sanofi, Waltham, Massachusetts 02451, USA.
Fabien PertuymRNA Center of Excellence, Sanofi, Waltham, Massachusetts 02451, USA.
Dinghai ZhengmRNA Center of Excellence, Sanofi, Waltham, Massachusetts 02451, USA.
Jun WangmRNA Center of Excellence, Sanofi, Waltham, Massachusetts 02451, USA.
Akshay BalsubramanimRNA Center of Excellence, Sanofi, Waltham, Massachusetts 02451, USA.
Khang TranmRNA Center of Excellence, Sanofi, Waltham, Massachusetts 02451, USA.
Minnie ZachariamRNA Center of Excellence, Sanofi, Waltham, Massachusetts 02451, USA.
Monica WumRNA Center of Excellence, Sanofi, Waltham, Massachusetts 02451, USA.
Xiaobo GumRNA Center of Excellence, Sanofi, Waltham, Massachusetts 02451, USA.
Ryan ClintonmRNA Center of Excellence, Sanofi, Waltham, Massachusetts 02451, USA.
Carla AsquithmRNA Center of Excellence, Sanofi, Waltham, Massachusetts 02451, USA.
Joseph SkaleskimRNA Center of Excellence, Sanofi, Waltham, Massachusetts 02451, USA.
Lianne BoeglinmRNA Center of Excellence, Sanofi, Waltham, Massachusetts 02451, USA.
Sudha ChivukulamRNA Center of Excellence, Sanofi, Waltham, Massachusetts 02451, USA.
Anusha DiasmRNA Center of Excellence, Sanofi, Waltham, Massachusetts 02451, USA.
Tod StrugnellmRNA Center of Excellence, Sanofi, Waltham, Massachusetts 02451, USA.
Fernando Ulloa MontoyamRNA Center of Excellence, Sanofi, 69280 Marcy L'Etoile, France.
Vikram AgarwalmRNA Center of Excellence, Sanofi, Waltham, Massachusetts 02451, USA.
Ziv Bar-JosephDigital R&D, Sanofi, Cambridge, Massachusetts 02141, USA; zivbj@cs.cmu.edu sven.jager@sanofi.com.ORCID 0000-0003-3430-6051
Sven JagerDigital R&D, Sanofi, Cambridge, Massachusetts 02141, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

mRNA-based vaccines and therapeutics are gaining popularity and usage across a wide range of conditions. One of the critical issues when designing such mRNAs is sequence optimization. Even small proteins or peptides can be encoded by an enormously large number of mRNAs. The actual mRNA sequence can have a large impact on several properties, including expression, stability, immunogenicity, and more. To enable the selection of an optimal sequence, we developed CodonBERT, a large language model (LLM) for mRNAs. Unlike prior models, CodonBERT uses codons as inputs, which enables it to learn better representations. CodonBERT was trained using more than 10 million mRNA sequences from a diverse set of organisms. The resulting model captures important biological concepts. CodonBERT can also be extended to perform prediction tasks for various mRNA properties. CodonBERT outperforms previous mRNA prediction methods, including on a new flu vaccine data set.

Indexed as

mRNA VaccinesRNA, MessengerAlgorithmsCodonHumansCodonmRNA VaccinesRNA, Messenger

Identifiers

PMID38951026
PMCPMC11368176

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.